Article · 5 Oct 2026
Conference abstract
Fascin and versican in acute leukemia: Clinical significance and clinicopathologic correlation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Fascin and Versican are involved in proliferation, migration and invasion of cancer cells. In spite of this pivotal role of both Fascin and Versican in many types of human malignancies, little is known about their role in acute leukemia. Objective: To measure plasma and leukocytes concentrations of Fascin and Versican in patients with acute leukemia, and to correlate the results with clinical features and treatment outcome. Method: Twenty-four patients with acute myeloid leukemia (AML), sixteen patients with acute lymphoblastic leukemia (ALL) and fifteen control subjects were included in the current study. Fascin and Versican were measured in plasma and leukocytes of all subjects by enzyme-linked immunosorbent assay kits provided by MyBioSource Inc., (San Diego, CA, USA). Results: Plasma Fascin significantly increased in AML, but not ALL cases. Plasma and leukocytes Versican significantly increased in AML compared to both control and ALL cases. Plasma Versican correlated with poor response to induction chemotherapy in AML cases. Conclusion: All together, Versican may be used as a diagnostic biomarker for AML. The plasma level of Versican could be a novel predictive marker of the response to induction chemotherapy in AML. In addition, plasma Fascin is a potential biomarker for AML.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Nabila Mohamed Hosni El Kramani”